On the other hand, in the context of hepatic insulin resistance, a typical pathway‐selective insulin responsiveness, insulin fails to suppress hepatic glucose production but stimulates lipogenesis, resulting in hyperglycaemia, hyperlipidaemia and hepatic steatosis [28]. The gene discussed is INS; the disease is Hyperglycemia.